Reliability of end-tidal carbon dioxide as a surrogate for arterial carbon dioxide assessment in infants undergoing thoracoscopic surgery with one-lung ventilation.

BACKGROUND

The reliability of end-tidal carbon dioxide (EtCO₂) as a surrogate for arterial arterial carbon dioxide partial pressure (PaCO₂) during one-lung ventilation (OLV) in infants is uncertain. This study evaluated EtCO₂-PaCO₂ agreement in infants undergoing OLV and identified factors associated with clinically significant discrepancy.

METHODS

This secondary analysis of a prospective, randomized controlled trial included 172 infants (aged ≤ 2 years) undergoing thoracoscopic surgery. Paired PaCO₂ and EtCO₂ measurements were obtained 20 min after initiating OLV. Clinical agreement was defined a priori as an absolute difference of ≤ 5 mmHg. Statistical evaluations included Bland-Altman analysis and multivariable logistic regression to identify predictors of disagreement, and correlation analyses.

RESULTS

During OLV, the mean EtCO₂-PaCO₂ bias was 2.8 mmHg with wide 95% limits of agreement (-4.7 to 10.3 mmHg), exceeding the clinically acceptable threshold. Oxygenation impairment (PaO₂/FiO₂ < 200 mmHg) significantly reduced the proportion of clinically acceptable measurements (55.9% vs. 81.7%, P = 0.0001). In multivariable analysis, EtCO₂-PaCO₂ disagreement occurred exclusively in infants ventilated under the non-protective protocol (VT 8 mL/kg with ZEEP). After excluding ventilatory variables that were structurally confounded with randomized allocation, lower lung compliance was independently associated with disagreement (adjusted OR 1.66, 95% CI 1.05-2.64, P = 0.030).

CONCLUSIONS

EtCO₂ provides only limited reliability as a stand-alone substitute for arterial blood gas analysis in infants during OLV, particularly under non-protective ventilation. The lung-protective ventilation strategy as a composite intervention is associated with substantially improved EtCO₂-PaCO₂ agreement during OLV in infants. Among individual patient-level factors, lower lung compliance independently predicts EtCO₂-PaCO₂ disagreement and may serve as a bedside indicator for clinicians to consider supplementary arterial blood gas analysis.